Correlates of bleeding events among moderate- to high-risk patients undergoing percutaneous coronary intervention and treated with eptifibatide: observations from the PROTECT-TIMI-30 trial. - Kirtane AJ; Piazza G; Murphy SA; Budiu D; Morrow DA; Cohen DJ; Peterson E; Lakkis N; Herrmann HC; Palabrica TM; Gibson CM; TIMI Study Group; et al. (Journal of the American College of Cardiology (JACC), 2006)